CEPI and Serum Institute of India collaborate to develop pandemic vaccines targeting Disease X with baculovirus technology.

Next-generation vaccines enhance immunization with precision-targeted immune responses, transforming public health and addressing global health challenges.

Expert Rev Vaccines. 2008;7(2):223-240. The EMVI is currently supporting preclinical activities at the Statens Serum Institute in Copenhagen and the Institut Pasteur in Paris for the development of a ...

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...

A government veterinarian vaccinates livestock in Naivasha following an outbreak of foot and mouth disease in the sub-county. The county government has banned the movement of livestock following an ...

Partners will advance end-to-end development of biologics for regionally prioritized diseases starting with Mpox and HIV CAIRO, EGYPT; BERLIN, GERMANY; AND NEW YORK, NY / ACCESS Newswire / October 10, ...

The US health secretary claimed mRNA vaccines are ineffective against respiratory diseases, while announcing he was cutting half a billion dollars in funding for mRNA vaccine development. But this ...

The handful of drugmakers dominating the global coronavirus vaccine race are pushing the boundaries of vaccine technology. The next crop under development feature more conventional, proven designs.